Genomic Valley Biotech share news, announcements and annual reports
BSE: 539206Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 29 Oct 2026. Previous close ₹43.63.
29 Oct: open ₹45.81, high ₹45.81, low ₹45.81
- Under BSE's graded surveillance, stage 0, and long-term additional surveillance, stage I, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 30 Oct 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14 Cr4,774th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 689.29
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 555
Genomic Valley Biotech has 490 announcements on record, routine notices left out; 5 in the 30 days to 30 Oct 2026, the latest on 27 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Genomic Valley Biotech quarterly results
The board meets on 30 Oct 2026 to consider quarterly results
Notice filed 21 Oct 2026
Genomic Valley Biotech annual reports, presentations and earnings calls
The company's own documents, latest first.Genomic Valley Biotech financials, year by year
Annual reports14
- Annual report, year to Mar 20259 Dec 2025
- Annual report, year to Mar 20247 Dec 2024
- Annual report, year to Mar 20237 Sep 2023
- Annual report, year to Mar 20226 Dec 2022
- Annual report, year to Mar 20217 Dec 2021
9 earlier reports
- Annual report, year to Mar 20207 Dec 2020
- Annual report, year to Mar 201929 Jul 2019
- Annual report, year to Mar 201818 Oct 2018
- Annual report, year to Mar 201712 Oct 2017
- Annual report, year to Mar 20166 Oct 2016
- Annual report, year to Mar 20157 Sep 2015
- Annual report, year to Mar 2014Filing day not known
- Annual report, year to Mar 2013Filing day not known
- Annual report, year to Mar 2012Filing day not known
Genomic Valley Biotech share news and announcements
Newest first. Page 1 of 10.
Oct 2026
27 Oct · Detailed Public Statement
21 Oct · Board meeting
Meeting on 30 Oct 2026: quarterly results20 Oct · Disclosure Under Regulation 30 And Regulation 30A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI (LODR) Regulations')
Aug 2026
14 Aug · Results
6 Aug · Board meeting
Meeting on 14 Aug 2026: quarterly results
May 2026
18 May · Board meeting
Meeting on 29 May 2026: quarterly results and audited results
Apr 2026
Jan 2026
5 Jan · Board meeting
Meeting on 15 Jan 2026: quarterly results
Dec 2025
8 Dec · Board meeting
Meeting on 8 Dec 2025: annual general meeting8 Dec · Corporate action
Oct 2025
7 Oct · Board meeting
Meeting on 15 Oct 2025: quarterly results
Sep 2025
Aug 2025
Jul 2025
29 Jul · Board meeting
Meeting on 7 Aug 2025: quarterly results
Jun 2025
May 2025
22 May · Board meeting
Meeting on 30 May 2025: audited results and quarterly results
Feb 2025
10 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 16 Jan 2026Board or managers changedup 4.66%+4.6 pts vs Nifty 500market median 0.0% · five sessions +5.0% (+7.0 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 9 Jan 2025Board or managers changedup 1.32%+2.1 pts vs Nifty 500market median 0.0% · five sessions −17.3% (−14.2 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 9 Dec 2024Board or managers changedup 1.07%+1.2 pts vs Nifty 500market median 0.0% · five sessions −5.2% (−5.4 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 9 Sep 2024Board or managers changed0.00%−0.1 pts vs Nifty 500market median 0.0% · five sessions +3.5% (+1.6 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 15 Feb 2024Board or managers changeddown 1.33%−1.9 pts vs Nifty 500market median 0.0% · five sessions −6.3% (−7.4 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 15 Dec 2023Board or managers changeddown 1.46%−2.4 pts vs Nifty 500market median 0.0% · five sessions +15.7% (+15.8 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 15 Nov 2023Board or managers changedup 4.97%+3.9 pts vs Nifty 500market median 0.0% · five sessions +13.4% (+11.6 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 3 Oct 2023Board or managers changedup 2.25%+2.5 pts vs Nifty 500market median 0.0% · five sessions −1.9% (−0.9 pts vs Nifty 500) · volume 1.4× usual · The announcement